Wall Street Leans Forward Pre-Bell; Futures Green, Europe Higher, Asia Closes Up

Wall Street Leans Forward Pre-Bell; Futures Green, Europe Higher, Asia Closes Up

Wall Street pre-bell Monday is optimistic, with U.S. stock index futures pointing to an opening bell up 0.50% or more from Friday’s close, with the Nasdaq even higher. European bourses are trading markedly higher, while Asian exchanges closed broadly up, as the weekend passed without a missile launch from North Korea, reducing perceived tensions. Gold, yen and sovereign bonds weakened. Hurricane Irma has landed in Florida, but has been downgraded […]

Read More ˃
Statoil Says ‘Disappointed’ in Non-Commercial Gas Find in Korpfjell Well

Statoil Says ‘Disappointed’ in Non-Commercial Gas Find in Korpfjell Well

Statoil ASA (STO) said Tuesday it and its partners have proven a small, non-commercial gas volume in the Korpfjell well in the Barents Sea. “The results are of course disappointing, but it is too early to draw any conclusions on how this will impact the Barents Sea southeast area,” said Jez Averty, head of exploration in Norway and the UK. “Korpfjell is a structure of a size seldom seen on […]

Read More ˃
Biogen Reports Phase 1 Results

Biogen Reports Phase 1 Results

Biogen Monday reported results from an analysis of the long-term extension of its ongoing phase 1b study of aducanumab, a drug to treat early Alzheimer’s disease, support the design of ongoing phase 3 studies of the drug. Biogen said patients who completed the 54-week, placebo-controlled period of the phase 1b study had the option to continue in a long-term extension of the clinical trial. Biogen reported that amyloid plaque in […]

Read More ˃
AcelRx Pharmaceuticals Amends Manufacturing Services Deal with Pantheon

AcelRx Pharmaceuticals Amends Manufacturing Services Deal with Pantheon

AcelRx Pharmaceuticals (ACRX) said Wednesday it has entered into the second amendment to the manufacturing services agreement with Patheon Pharmaceuticals, Inc. related to the manufacture of sufentanil sublingual tablets for use with the company’s product candidate, Dsuvia (known as ARX-04 outside the U.S.) Under the terms of the agreement, Patheon will manufacture, supply, and provide certain validation and stability services for the product intended for marketing and sale in U.S., […]

Read More ˃
Aradigm Wins NIH Grant

Aradigm Wins NIH Grant

Aradigm said Tuesday it has won a small business initiative research grant from the National Institute of Allergy and Infectious Diseases and National Institutes of Health to investigate the treatment of two pulmonary non-tuberculous mycobacteria infections with the company’s inhaled liposomal ciprofloxacin products Linhaliq and Lipoquin. The two infections are mycobacterium avium and mycobacterium abscessus. The principal investigator is James Blanchard, principal scientist of preclinical development at Aradigm. Luiz Bermudez […]

Read More ˃